SM

Swati Mandar Ghonge

Director Additional Director DIN 03011630
DIN 03011630 First appointment Mar 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Swati Mandar Ghonge

Data last updated:

Swati Mandar Ghonge was an Additional Director at Dutch Remedies Private Limited (2010–2011) and Director at D.K.Dhawale Impex Private Limited (from 2012). The companies operate in Pharma.

DIN 03011630
Primary Designation Additional Director
Industry Pharma
First Appointment 18 Mar 2010
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dutch Remedies Private Limited U51397MH2004PTC146333
Additional Director18 Mar 20102004Active
D.K.Dhawale Impex Private Limited U51101MH2012PTC225626
Director02 Jan 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
D.K.Dhawale Impex Private Limited
Dutch Remedies Private Limited
Premium access

Shareholding and investment profile for Swati Mandar Ghonge

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Mandar Ghonge

Swati Mandar Ghonge was first appointed on 18 Mar 2010 as Additional Director at Dutch Remedies Private Limited. The most recent appointment on record is 02 Jan 2012 at D.K.Dhawale Impex Private Limited.

Swati Mandar Ghonge held 2 earlier board appointments: Dutch Remedies Private Limited (Additional Director, 18 Mar 2010 to 23 Jul 2011); D.K.Dhawale Impex Private Limited (Director, from 02 Jan 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available